Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lianes

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancerD Castellano, P Lianes, L Paz-Ares, et al.
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsT Le Chevalier, D Brisgand, J Y Douillard, et al.
International Journal of Oncology|July 17, 1998
Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relativesE Garcia-Patińo, B Gomendio, J M Silva, et al.
The American Journal of Pathology|May 1, 1995
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppressionN A Gruis, J Weaver-Feldhaus, Q Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal typeA Hasbini, R Mahjoubi, A Fandi, et al.
Journal of the National Cancer Institute|June 7, 1995
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factorsJ I Mayordomo, F Rivera, M T Díaz-Puente, et al.
Revista Clinica Espanola|November 1, 1994
[A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients]J L González Larriba, V Alberola, P Lianes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2013
Lung cancer in women: an overview with special focus on Spanish womenJ Remon, E Molina-Montes, M Majem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker NetworkP Lianes, E Charytonowicz, C Cordon-Cardo, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancerD Castellano, P Lianes, L Paz-Ares, et al.
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsT Le Chevalier, D Brisgand, J Y Douillard, et al.
International Journal of Oncology|July 17, 1998
Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relativesE Garcia-Patińo, B Gomendio, J M Silva, et al.
The American Journal of Pathology|May 1, 1995
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppressionN A Gruis, J Weaver-Feldhaus, Q Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal typeA Hasbini, R Mahjoubi, A Fandi, et al.
Journal of the National Cancer Institute|June 7, 1995
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factorsJ I Mayordomo, F Rivera, M T Díaz-Puente, et al.
Revista Clinica Espanola|November 1, 1994
[A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients]J L González Larriba, V Alberola, P Lianes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2013
Lung cancer in women: an overview with special focus on Spanish womenJ Remon, E Molina-Montes, M Majem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker NetworkP Lianes, E Charytonowicz, C Cordon-Cardo, et al.
Pageof 5